Severe acute pancreatitis (SAP) remains one of the most formidable challenges in gastrointestinal emergency medicine.
Mayo Clinic researchers have identified an immune-regulating molecule that may help explain why some patients with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, ...
Eating habits shape gut bacteria in children with autism, with potential dietary interventions offering hope for improving ...
IBD is an immune condition. Instead of peacefully coexisting with gut microbes, the immune system becomes overly reactive, ...
A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted ...
A research team has made further progress in the treatment of intestinal inflammation. A study shows that the semi-synthetic bile acid NorUDCA inhibits in the intestine the formation of ...
Research by Milena Bogunovic, MD, Ph.D., associate professor of pathology, sheds light on how inflammation in the gastrointestinal (GI) tract, such as that associated with inflammatory bowel disease ...
Researchers have developed a stem cell-based model of the human intestine that may transform how new IBD treatments are ...
Despite an expanding therapeutic armamentarium, remission rates in inflammatory bowel disease (IBD) appear to plateau at 30–50% after 1 year of treatment, leading to the concept of a therapeutic ...
Scientists recently discovered that glycyrrhizin, a substance taken from black licorice root, may reduce inflammation and ...
A new study published in Stem Cell Reports demonstrates how a human stem cell-derived model of the intestine can be used to identify potential therapies for inflammatory bowel disease (IBD), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results